248 related articles for article (PubMed ID: 34008450)
1. Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice.
Tanqueiro SR; Mouro FM; Ferreira CB; Freitas CF; Fonseca-Gomes J; Simões do Couto F; Sebastião AM; Dawson N; Diógenes MJ
J Psychopharmacol; 2021 Jun; 35(6):730-743. PubMed ID: 34008450
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
Klamer D; Svensson L; Fejgin K; Pålsson E
Eur Neuropsychopharmacol; 2011 Mar; 21(3):248-53. PubMed ID: 21111580
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling.
Tan Y; Fujita Y; Qu Y; Chang L; Pu Y; Wang S; Wang X; Hashimoto K
Pharmacol Biochem Behav; 2020 Jan; 188():172839. PubMed ID: 31866390
[TBL] [Abstract][Full Text] [Related]
4. Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction.
Ponserre M; Ionescu TM; Franz AA; Deiana S; Schuelert N; Lamla T; Williams RH; Wotjak CT; Hobson S; Dine J; Omrani A
Neuropharmacology; 2024 Aug; 254():109970. PubMed ID: 38685343
[TBL] [Abstract][Full Text] [Related]
5. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
Castañé A; Santana N; Artigas F
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
[TBL] [Abstract][Full Text] [Related]
6. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
7. Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks.
Dawson N; Xiao X; McDonald M; Higham DJ; Morris BJ; Pratt JA
Cereb Cortex; 2014 Feb; 24(2):452-64. PubMed ID: 23081884
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice.
Xu J; Kurup P; Baguley TD; Foscue E; Ellman JA; Nairn AC; Lombroso PJ
Cell Mol Life Sci; 2016 Apr; 73(7):1503-14. PubMed ID: 26450419
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain.
Snigdha S; Neill JC; McLean SL; Shemar GK; Cruise L; Shahid M; Henry B
J Mol Neurosci; 2011 Mar; 43(3):337-45. PubMed ID: 20852970
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
11. The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia.
Blot K; Bai J; Otani S
J Physiol Paris; 2013 Dec; 107(6):448-51. PubMed ID: 23603055
[TBL] [Abstract][Full Text] [Related]
12. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Jodo E
J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
[TBL] [Abstract][Full Text] [Related]
13. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.
Hashimoto T; Bergen SE; Nguyen QL; Xu B; Monteggia LM; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2005 Jan; 25(2):372-83. PubMed ID: 15647480
[TBL] [Abstract][Full Text] [Related]
14. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wetchateng T; Sireeratawong S
J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
[TBL] [Abstract][Full Text] [Related]
15. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
Newell KA; Zavitsanou K; Huang XF
J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
[TBL] [Abstract][Full Text] [Related]
16. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
[TBL] [Abstract][Full Text] [Related]
17. Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure.
Wang X; Gu Z; Zhong P; Chen G; Feng J; Yan Z
Mol Cell Neurosci; 2006 Jan; 31(1):15-25. PubMed ID: 16198123
[TBL] [Abstract][Full Text] [Related]
18. Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory.
Camer D; Yu Y; Szabo A; Fernandez F; Dinh CHL; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():68-75. PubMed ID: 25584778
[TBL] [Abstract][Full Text] [Related]
19. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.
Balu DT; Li Y; Puhl MD; Benneyworth MA; Basu AC; Takagi S; Bolshakov VY; Coyle JT
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):E2400-9. PubMed ID: 23729812
[TBL] [Abstract][Full Text] [Related]
20. Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats.
Loureiro CM; Fachim HA; Harte MK; Dalton CF; Reynolds GP
J Psychopharmacol; 2022 Feb; 36(2):238-244. PubMed ID: 35102781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
